Adaptive learning to address gaps in metastatic breast cancer treatment with CDK 4/6 inhibitors

Accepted for presentation at ASCO 2024 Quality Care Symposium in San Francisco on September 27-28.

Project was in collaboration with Antidote Education and funded by Pfizer